FDA Inspection 1221771 — Veselin Palazov
The FDA completed an inspection of Veselin Palazov on Oct 19, 2023 in Burgas. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 19, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Burgas (Bulgaria)
Additional Details
Clinical Investigator (CI)